Halbert Hargrove Russell LLC lessened its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 24.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,424 shares of the medical research company’s stock after selling 455 shares during the quarter. Halbert Hargrove Russell LLC’s holdings in Thermo Fisher Scientific were worth $269,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Amalgamated Bank raised its position in shares of Thermo Fisher Scientific by 57.0% during the 2nd quarter. Amalgamated Bank now owns 44,921 shares of the medical research company’s stock valued at $7,837,000 after buying an additional 16,308 shares during the period. Mutual of America Capital Management LLC raised its position in Thermo Fisher Scientific by 2.1% in the second quarter. Mutual of America Capital Management LLC now owns 47,728 shares of the medical research company’s stock valued at $8,327,000 after purchasing an additional 977 shares during the period. Mitchell Capital Management Co. raised its position in Thermo Fisher Scientific by 40.3% in the second quarter. Mitchell Capital Management Co. now owns 44,940 shares of the medical research company’s stock valued at $7,841,000 after purchasing an additional 12,910 shares during the period. State Board of Administration of Florida Retirement System raised its position in Thermo Fisher Scientific by 0.9% in the second quarter. State Board of Administration of Florida Retirement System now owns 580,712 shares of the medical research company’s stock valued at $101,317,000 after purchasing an additional 5,213 shares during the period. Finally, San Francisco Sentry Investment Group CA purchased a new stake in Thermo Fisher Scientific in the second quarter valued at approximately $1,451,000. 85.32% of the stock is currently owned by hedge funds and other institutional investors.

In other news, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total transaction of $9,419,500.00. Following the sale, the chief executive officer now owns 252,577 shares of the company’s stock, valued at $47,582,981.03. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Peter E. Hornstra sold 3,894 shares of the company’s stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $185.18, for a total value of $721,090.92. Following the sale, the vice president now directly owns 19,751 shares in the company, valued at approximately $3,657,490.18. The disclosure for this sale can be found here. Insiders have sold 56,280 shares of company stock worth $10,572,385 in the last ninety days. Corporate insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Inc (NYSE TMO) traded up $0.76 during trading on Monday, hitting $193.51. The stock had a trading volume of 374,400 shares, compared to its average volume of 1,537,888. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $201.20. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. The stock has a market capitalization of $77,190.00, a price-to-earnings ratio of 21.26, a P/E/G ratio of 1.77 and a beta of 1.08.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The business had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the prior year, the company earned $2.03 earnings per share. The company’s revenue was up 13.9% on a year-over-year basis. equities research analysts expect that Thermo Fisher Scientific Inc will post 9.36 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.

TMO has been the topic of a number of research analyst reports. Zacks Investment Research lowered Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. BidaskClub lowered Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Argus reissued a “buy” rating on shares of Thermo Fisher Scientific in a research report on Tuesday, August 22nd. They noted that the move was a valuation call. Cowen Inc reissued a “buy” rating and issued a $200.00 target price on shares of Thermo Fisher Scientific in a research report on Friday, September 1st. Finally, Morgan Stanley reissued an “overweight” rating and issued a $220.00 target price on shares of Thermo Fisher Scientific in a research report on Wednesday, September 6th. One research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Thermo Fisher Scientific presently has an average rating of “Buy” and a consensus price target of $205.71.

TRADEMARK VIOLATION WARNING: This piece was originally published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another site, it was illegally copied and republished in violation of US & international copyright law. The legal version of this piece can be read at https://www.watchlistnews.com/halbert-hargrove-russell-llc-has-269000-stake-in-thermo-fisher-scientific-inc-tmo/1729522.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.